Animal experiment models have demonstrated that implantation of autologous bone marrow mononuclear cells (BM-MNC) is an effective technique for inducing therapeutic angiogenesis. Histological studies have shown an increase in the capillary/muscle fibre ratio with incorporation of implanted cells into the vasculature. In humans, clinical improvement has been reported in patients with critical limb ischaemia (CLI). 1 However, few histological data have been yet provided in patients after cell therapy. We had the opportunity to observe histological changes in two patients who required amputation after cell therapy.
In October 2004 we initiated a prospective non randomised trial to evaluate the feasibility and efficacy of implanting autologous BM-MNC in patients presenting with CLI related to atherosclerosis obliterans who had no possibility of surgical or endovascular revascularization. The study protocol was approved by the Ethics Committee and written informed consent for participation was obtained from all subjects. BM-MNC were collected as described previously. 1 Briefly, 500 ml of bone marrow were collected under general anaesthesia. MNC were separated using a blood-cell separator (COBE SPECTRA, GAM-BRO BCT, Lakewood, USA) and concentrated to produce a final volume of 40 ml. Cell implantation was performed within 8 h after cell collection, by 30 trans-cutaneous injections of 1 ml of cell suspension into the gastrocnemius muscle. Clinical parameters, ankle-brachial pressure index (ABPI), trans-cutaneous oxygen pressure (TcPO2) and biological parameters were then monitored.
Patient 1 was a 71-year-old man who presented with CLI secondary to the occlusion of a left femoro-tibial graft implanted 5 years earlier. ABPI and TcPO2 were respectively 0 and 1 mm Hg and he had a necrotic big toe, which had been present for 1 month. The cellular concentrate contained 4.6 Â 10 8 BM-MNC, among which 16.0 Â 10 6 , 11 Â 10 6 and 0.11 Â 10 6 were respectively CD34 
deterioration, amputation of the leg was performed on day 44. Both patients were treated with antiagregant medications and statins before and after cell implantation and had ceased smoking. No additional therapeutic measures were undertaken between cell therapy and amputation. After leg amputation, muscle samples were harvested from the gastrocnemius at four levels, in both cases, superior limit of excision (i.e. above the area of cell implantation) and proximal, mid and distal calf. Samples were fixed overnight in 4% formalin, and then processed in paraffin blocks. Three-micrometer sections were stained with hematoxylin-eosin-saffron (HES). Immunostaining was performed on selected blocks using the following antibodies: CD3, CD20, CD31, CD34, CD68, CD79a, CD117 (c-kit), Willebrand factor, actin, desmin and myeloperoxidase (MPO). Three legs amputated from CLI patients treated by the same team without cell therapy, were used as controls.
On HES slides, muscle histology was normal at the upper limit of muscle resection. Conversely, prominent oedema was observed in the fascicles and in the inter-fascicular compartment of the lower sites. Oedema was more pronounced in the middle and distal parts of the muscle and was associated with shrinkage of muscle fibres and with large numbers of capillaries running along the side of muscle fibres. Two particular kinds of change were observed. First, in the peri-fascicular compartments, a rim of mononuclear cells was observed around small arteries and veins (media was actin and desmin positive); on immunochemistry analysis, these cells were T (CD3-positive) and B-lymphocyte (CD20 and CD79a positive) and histiocyte (CD68-positive); none of these cells expressed stem cell markers (CD34 or c-kit) or MPO; numerous vasa vasorum budding from parent vessels were identified; their endothelial cells expressed c-kit, whereas endothelial cells of parent vessels did not ( Figure 1) ; all endothelial cells expressed CD31, CD34 and Willebrand factor. Second, in some fields, large numbers of intrafascicular capillaries expressed c-kit, whereas vessels in adjacent fascicles did not (Figure 2 ). These changes were present in both patients and were not observed in control muscle samples: neither oedema, nor excessive amounts of capillaries were seen; no inflammatory cells were found around blood vessels and no c-kit expression was demonstrated in small vessels.
These data show that intra-muscular implantation of BM-MNC induces significant histological changes that do not exist in control patients presenting with CLI. Oedema may be owing to local VEGF production or the inflammatory process. It is noteworthy that endothelial cells express c-kit whose importance in angiogenesis has been outlined. 2 
